Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Study of inducible HLA-G+ Regulatory T Cells (iG-Tregs) in HLA-matched sibling allo-HCT
2024-520084-14-00Phase 2Authorised
- Sponsor
- University of Patras
- Start
- Jan 2025
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of iG-Tregs in graft-versus-host disease (GVHD), sponsored by University of Patras. Planned start Jan 2025; status: authorised.
02
Drugs
iG-Tregs
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2024-520084-14-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520084-14-00.